{Reference Type}: Journal Article
{Title}: Headache Associated with Coronavirus Disease 2019.
{Author}: Sampaio Rocha-Filho PA;
{Journal}: Neurol Clin
{Volume}: 42
{Issue}: 2
{Year}: 2024 May
{Factor}: 3.787
{DOI}: 10.1016/j.ncl.2023.12.006
{Abstract}: Headache affects around half of patients in the acute phase of COVID-19 and generally occurs at the beginning of the symptomatic phase, has an insidious onset, and is bilateral, and of moderate to severe intensity. COVID-19 may also present complications that cause acute and persistent headaches, such as cerebrovascular diseases, rhinosinusitis, meningitis, and intracranial hypertension. In 10% to 20% of patients with COVID-19, headache may persist beyond the acute phase. In general, the headache improves over time. To date, there are no clinical trials that have assessed the treatment of persistent post-COVID-19 headache.